{"id":37536,"topic":"peptides","source":"Cureus","title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","url_hash":"b50dc596500e5807b28877cf9bd998c24fab2db6","author":"","summary":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","content":null,"image_url":null,"lang":"en","published_at":"2026-07-15T14:57:33+00:00","fetched_at":"2026-07-15T15:15:08+00:00","status":"read","starred":0,"extract_state":"failed","summary_auto":null,"cluster_id":null,"extract_retries":2,"extract_error":"trafilatura_none","contract_version":"news_item.v1","format_contract_version":"news_item_formats.v1","dedup_url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}},"news_item":{"id":37536,"canonical_url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","source_url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","source_name":"Cureus","author":null,"published_at":"2026-07-15T14:57:33+00:00","locale":"en","topic":"peptides","tags":[],"rss_summary":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","full_text":null,"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}}},"display_formats":["compact","card","full","digest_section","json"]},"daily_stack_record":{"title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","summary":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","source":"Cureus","date":"2026-07-15T14:57:33+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}},"tags":[]},"fallback_formats":["markdown","json","html"],"actions":{"read":"/item/37536","export_markdown":"/api/items/37536/export?format=markdown","export_json":"/api/items/37536/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus"},"formats":{"full":{"id":37536,"title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","source":"Cureus","author":null,"published_at":"2026-07-15T14:57:33+00:00","locale":"en","topic":"peptides","tags":[],"excerpt":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","full_text":null,"reading_time_min":1,"extraction":{"state":"failed","confidence":0.2,"error":"trafilatura_none","explanation":"Low confidence: extractor returned no usable article text.","diagnostics_url":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}}},"quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}},"actions":{"read":"/item/37536","export_markdown":"/api/items/37536/export?format=markdown","export_json":"/api/items/37536/export?format=json","diagnose":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus"}},"digest":{"id":37536,"title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","source":"Cureus","topic":"peptides","published_at":"2026-07-15T14:57:33+00:00","excerpt":"<a…","quality_bucket":"low","quality_reason":"Low confidence: extractor returned no usable article text.","reading_time_min":1,"cluster_id":null},"card":{"display_title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","subtitle":"Cureus · 2026-07-15","summary":"<a…","badges":["quality:low","issue:extractor_empty"],"links":{"read":"/item/37536","original":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","diagnose":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus"},"quality_warning":"Low confidence: extractor returned no usable article text."},"export":{"title":"Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus? - Cureus","url":"https://www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","summary":"<a href=\"https://news.google.com/rss/articles/CBMi3wJBVV95cUxPMm84aGZqdzlrbS00WFJLaDkxVzVIdDBMNTJxWWRocnJuWUt4VkR3dnZ0MnRNNG10LXM2NVNfXzBaLTFubGdEYU1NTnd1ZDhra2xuV2w2QUhiSWxseF83ZmFUbVRQak85UW44d1pFbkN1Y1BOeVR2bkY4YjdqeWhzVmZ0UVN0Qk9qQU95bVRIM2tkTmVjckZCbDVGcE1hQXpjODUwMl9aYUVtdU9pQnNDWEQ4QW40RmdaYkR0eHpNNVZkQVd2QlFHeUstcmlYRnh3dFBuYlhLeVExMW9NbTd5NGZYc0NaQ2pQd3NCb08yUG5wY0FNcGh5RTRlVUFkTzRNMGJ5MHpPb3dkR0NiSWpnTEZpS0laemFfdTdqazI1UDZ2OVhKeklyZThTUHhmYTRfVzY4ZGR3enk5WDBCMHpISUczT1NrYVQ2d2U3M01KZ243WUtvcTJRdTd0alpVaGs?oc=5\" target=\"_blank\">Does Combination Therapy With a Glucagon-Like Peptide-1 Receptor Agonist and a Sodium-Glucose Cotransporter 2 Inhibitor Enhance Cardiovascular and Renal Protection in People With Type 2 Diabetes Mellitus?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Cureus</font>","source":"Cureus","date":"2026-07-15T14:57:33+00:00","content":"","confidence":0.2,"diagnostics_url":"/api/diagnose?url=https%3A//www.cureus.com/articles/465850-does-combination-therapy-with-a-glucagon-like-peptide-1-receptor-agonist-and-a-sodium-glucose-cotransporter-2-inhibitor-enhance-cardiovascular-and-renal-protection-in-people-with-type-2-diabetes-mellitus","quality_bucket":"low","failure_kind":"extractor_empty","retryable":false,"quality_reason":"Low confidence: extractor returned no usable article text.","quality_profile":{"profile_version":"extraction_quality.v2","bucket":"low","confidence":0.2,"failure_kind":"extractor_empty","retryable":false,"retry_after_attempts":0,"reason":"Low confidence: extractor returned no usable article text.","operator_guidance":{"severity":"warning","recommended_action":"use_summary_with_caveat","next_step":"Use the available summary only with a visible quality caveat.","operator_label":"Use summary with caveat","can_retry":false,"can_use_summary":true,"diagnostics_required":true},"content_depth":{"contract_version":"content_depth.v1","category":"summary_only","label":"Summary only","has_full_text":false,"has_summary":true,"content_length":0,"summary_length":799,"usable_text_length":799,"source_field":"summary"},"legacy_collapsed":false,"signals":{"extract_state":"failed","extract_error":"trafilatura_none","extract_retries":2,"content_length":0,"summary_length":799}},"tags":[],"format_contract_version":"news_item_formats.v1"}}}